Timing Is Everything for Merck’s COVID Pill: If a result comes too late, or a test seems out of reach, then the sick person can easily miss that crucial early-infection window—a big loss, considering that molnupiravir has essentially “no effect on patients once they’re in hospitals,” submitted by /u/shallah
[link] [comments]


from Health https://ift.tt/3ajG6KM
Share To:

Unknown

Post A Comment:

0 comments so far,add yours